Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:27 AM UTC
| NCT Number | NCT06345729 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of August 31, 2026: Clinical trial NCT06345729 is currently recruiting participants. This phase3 study for non-small cell lung cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06345729 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06345729 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.